Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: The MsFLASH experience

被引:22
|
作者
Sternfeld, Barbara [1 ]
LaCroix, Andrea [2 ]
Caan, Bette J. [1 ]
Dunn, Andrea L. [3 ]
Newton, Katherine M. [4 ]
Reed, Susan D. [5 ]
Guthrie, Katherine A. [2 ]
Booth-LaForce, Cathryn [6 ]
Sherman, Karen J. [4 ]
Cohen, Lee [7 ]
Freeman, Marlene P. [7 ]
Carpenter, Janet S. [8 ]
Hunt, Julie R. [2 ]
Roberts, Melanie [9 ]
Ensrud, Kristine E. [10 ]
机构
[1] Kaiser Permanente, Div Res, Oakland, CA 94612 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[3] Klein Buendel Inc, Denver, CO USA
[4] Grp Hlth Res Inst, Seattle, WA USA
[5] Univ Washington, Sch Med, Seattle, WA USA
[6] Univ Washington, Sch Nursing, Seattle, WA 98195 USA
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
[8] Indiana Univ, Sch Nursing, Indianapolis, IN 46204 USA
[9] Natl Inst Fitness & Sport, Indianapolis, IN USA
[10] Univ Minnesota, Dept Med, VA Med Ctr, Dept Med & Epidemiol, Minneapolis, MN 55455 USA
基金
美国国家卫生研究院;
关键词
Vasomotor symptoms; Randomized controlled trial; Yoga; Exercise; Omega-3 fatty acids; Factorial design; HEART-RATE-VARIABILITY; POSTMENOPAUSAL WOMEN; PHYSICAL-ACTIVITY; HOT FLASHES; HEALTH; YOGA; OMEGA-3-FATTY-ACIDS; THERAPY; FLUSHES; DISEASE;
D O I
10.1016/j.cct.2013.02.009
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Behavioral strategies are recommended for menopausal symptoms, but little evidence exists regarding efficacy. Purpose: Describe design and methodology of a randomized controlled 3 by 2 factorial trial of yoga, exercise and omega-3 fatty acids. Methods: Women from three geographic areas with a weekly average of >= 14 hot flashes/night sweats, who met exclusion/inclusion criteria, were randomized to 12 weeks of: 1) yoga classes and daily home practice; 2) supervised, facility-based aerobic exercise training; or 3) usual activity. Women in each arm were further randomized to either omega-3 supplement or placebo. Standardized training, on-going monitoring, and site visits were adopted to ensure consistency across sites and fidelity to the intervention. Participant adherence to the intervention protocol was monitored continuously, and retention was actively encouraged by staff. Information on adverse events was systematically collected. Results: Of 7377 women who responded to mass mailings, 355 (4.8%) were randomized; mean age was 54.7 (sd = 3.7), 26.2% were African American, 81.7% were post-menopausal, and mean baseline frequency of daily hot flashes/night sweats was 7.6 (sd = 3.8). Adherence of >= 80% was 59% for yoga, 77% for exercise training, and 80% for study pills. Final week 12 data were collected from 95.2% Conclusions: Conducting a multi-site, multi-behavioral randomized trial for menopausal symptoms is challenging but feasible. Benefits included cost-effective study design, centralized recruitment, and methodologic standardization. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:25 / 34
页数:10
相关论文
共 50 条
  • [1] BRIEF BEHAVIORAL ACTIVATION FOR DEPRESSIVE SYMPTOMS IN PRIMARY CARE: A MULTI-SITE RANDOMIZED CONTROLLED TRIAL
    Funderburk, Jennifer
    Pigeon, Wilfred
    Shepardson, Robyn L.
    Wray, Laura
    ANNALS OF BEHAVIORAL MEDICINE, 2020, 54 : S247 - S247
  • [2] The Rationale and Design of Behavioral Interventions for Management of Agitation in Dementia in a Multi-Site Clinical Trial
    Zarei, Shadi
    Colman, Sarah
    Rostas, Aviva
    Burhan, Amer M.
    Chu, Li
    Davies, Simon J. C.
    Derkach, Peter
    Elmi, Sarah
    Hussain, Maria
    Gerretsen, Philip
    Graff-Guerrero, Ariel
    Ismail, Zahinoor
    Kim, Donna
    Krisman, Linda
    Moghabghab, Rola
    Mulsant, Benoit H.
    Nair, Vasavan
    Pollock, Bruce G.
    Rej, Soham
    Simmons, Jyll
    Van Bussel, Lisa
    Rajji, Tarek K.
    Kumar, Sanjeev
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 86 (02) : 827 - 840
  • [3] COMMUNITY-BASED MULTI-SITE RANDOMIZED CONTROLLED TRIAL OF BEHAVIORAL ACTIVATION FOR PATIENTS WITH NEGATIVE SYMPTOMS
    Choi, Kee-Hong
    Lee, Eunbyeol
    Seo, Ho Jun
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S140 - S140
  • [4] Choice of control treatment in multi-site effectiveness behavioral trials
    Wakim, P
    Nunes, E
    Feaster, D
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 223S - 223S
  • [5] A MULTI-SITE, RANDOMIZED, CONTROLLED CLINICAL TRIAL OF BEHAVIORAL AND NUTRITION TREATMENT FOR PRESCHOOLERS WITH CYSTIC FIBROSIS
    Powers, S. W.
    Stark, L.
    Chamberlin, L.
    Sullivan, S.
    Filigno, S.
    Rausch, J.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 402 - 402
  • [6] Community-based multi-site randomized controlled trial of behavioral activation for patients with negative symptoms of schizophrenia
    Oh, Jihye
    Lee, Eunbyeol
    Cha, Eun Ji
    Seo, Ho-Jun
    Choi, Kee -Hong
    SCHIZOPHRENIA RESEARCH, 2023, 252 : 118 - 126
  • [7] Topiramate for the treatment of alcohol dependence: Results of a multi-site trial
    Johnson, B. A.
    Rosenthal, N.
    Capece, J.
    Wiegand, F.
    Mao, L.
    Beyers, K.
    McKay, A.
    Ait-Daoud, N.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 31 (06) : 261A - 261A
  • [8] Agile methods in biomedical software development: a multi-site experience report
    David W Kane
    Moses M Hohman
    Ethan G Cerami
    Michael W McCormick
    Karl F Kuhlmman
    Jeff A Byrd
    BMC Bioinformatics, 7
  • [9] Agile methods in biomedical software development: a multi-site experience report
    Kane, David W.
    Hohman, Moses M.
    Cerami, Ethan G.
    McCormick, Michael W.
    Kuhlmman, Karl F.
    Byrd, Jeff A.
    BMC BIOINFORMATICS, 2006, 7 (1)
  • [10] Multi-site collaboration in system on chip design and validation: The Intel experience
    Paranjape, Ketan
    PROCEEDINGS OF THE 2006 IEEE WORKSHOP ON DESIGN AND DIAGNOSTICS OF ELECTRONIC CIRCUITS AND SYSTEMS, 2006, : 1 - 1